Tissue Therapy. Implications of Regenerative Medicine for Skeletal Muscle

Principles of Regenerative Medicine

Volumn , Issue , 2008, Pages 1232-1247

  Wei, Shen ^a   Huard, Johnny ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72049116735     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369410-2.50074-7     Document Type: Chapter

References (107)

1. Almekinders L.C. Anti-inflammatory treatment of muscular injuries in sport.An update of recent studies. Sports Med 1999, 28(6):383-388.
2. Almekinders L.C., Gilbert J.A. Healing of experimental muscle strains and the effects of nonsteroidal antiinflammatory medication. Am. J. Sports Med. 1986, 14(4):303-308.
3. Amthor H., Nicholas G., McKinnell I., Kemp C.F., Sharma M., Kambadur R., Patel K. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev. Biol. 2004, 270(1):19-30.
4. Balaban B., Matthews .J., Clayton G.H., Carry T. Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect. Am. J. Phys. Med.. Rehab. 2005, 84(11):843-850.
5. Barton-Davis E.R., Shoturma .I., Musaro A., Rosenthal N., Sweeney H.L. Viral mediated expression of insulinlike growth factor I blocks the aging-related loss of skeletal muscle function. Proc. Natl Acad. Sci.USA 1998, 95(26):15603-15607.
6. Beaton L.J., Allan D.A., Tarnopolsky M.A., Tiidus P.M., Phillips S.M. Contraction-induced muscle damage is unaffected by vitamin E supplementation. Med. Sci. Sports Exerc. 2002, 34(5):798-805.
7. Beenakker E.A., Fock J.M., Van Tol M.J., Maurits N.M., Koopman H.M., Brouwer O.F., Van der Hoeven J.H. Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial. Arch. Neurol. 2005, 62(1):128-132.
8. Best T.M., Loitz-Ramage B., Corr D.T., Vanderby R. Hyperbaric oxygen in the treatment of acute muscle stretch injuries. Results in an animal model. Am. J. Sports Med. 1998, 26(3):367-372.
9. Bogdanovich S., Krag T.O., Barton E.R., Morris L.D., Whittemore L.A., Ahima R.S., Khurana T.S. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002, 420(6914):418-421.
10. Bondesen B.A., Mills S.T., Kegley K.M., Pavlath G.K. The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am. J. Physiol. Cell Physiol. 2004, 287(2):C475-C483.
11. Budasz-Rwiderska M., Jank M., Motyl T. Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts. J. Physiol. Pharmacol 2005, 56(Suppl 3):195-214.
12. Camargo F.D., Green R., Capetenaki Y., Jackson K.A., Goodell M.A. Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat. Med.. 2003, 9(12):1520-1527.
13. Campion D.R. The muscle satellite cell: a review. Int. Rev. Cytol. 1984, 87:225-251.
14. Cantini M., Massimino M.L., Bruson A., Catani C., Dalla Libera L., Carraro U. Macrophages regulate proliferation and differentiation of satellite cells. Biochem. Biophys. Res. Comm. 1994, 202(3):1688-1696.
15. Chan Y.S., Li Y., Foster ., Fu F.H., Huard J. The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am. J. Sports Med. 2005, 33(1):43-51.
16. Chazaud B., Sonnet C., Lafuste P., Bassez G., Rimaniol A.C., Poron F., Authier F.J., Dreyfus P.A., Gherardi R.K. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J. Cell. Biol. 2003, 163(5):1133-1143.
17. Childs A., Jacobs C., Kaminski T., Halliwell B., Leeuwenburgh C. Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise. Free Radical Biol. Med.. 2001, 31(6):745-753.
18. Clanton T.L., Zuo L., Klawitter P. Oxidants and skeletal muscle function: Physiologic and pathophysiologic implications. Proc. Soc. Exp. Biol. Med. 1999, 222(3):253-262.
19. Confalonieri P., Bernasconi P., Cornelio F., Mantegazza R. Transforming growth factor-beta 1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate. J. Neuropathol. Exp. Neurol. 1997, 56(5):479-484.
20. Darr K.C., Schultz E. Exercise-induced satellite cell activation in growing and mature skeletal muscle. J Appl Physiol 1987, 63(5):1816-1821.
21. Ebisui C., Tsujinaka T., Morimoto T., Kan K., Iijima S., Yano M., Kominami E., Tanaka K., Monden M. Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes. Clin. Sci. 1995, 89(4):431-439. (Lond).
22. Engert J.C., Berglund E.B., Rosenthal N. Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J. Cell Biol. 1996, 135(2):431-440.
23. Esser K.A., White T.P. Mechanical load affects growth and maturation of skeletal muscle grafts. J. Appl. Physiol. 1995, 78(1):30-37.
24. Fielding R.A., Manfredi T.J., Ding W., Fiatarone M.A., Evans W.J., Cannon J.G. Acute phase response in exercise. III. Neutrophil and IL-1 beta accumulation in skeletal muscle. Am. J. Physiol. 1993, 265:R166-R172. 1 Part 2.
25. Florini J.R., Ewton D.Z., Coolican S.A. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 1996, 17(5):481-517.
26. Forester G.V., Roy O.Z., Mortimer A.J. Enhancement of contractility in rat isolated papillary muscle with therapeutic ultrasound. J.Mol. Cell. Cardiol. 1982, 14(8):475-477.
27. Foster ., Li Y., Usas A., Somogyi G., Huard J. Gamma interferon as an antifibrosis agent in skeletal muscle. J. Orthop. Res. 2003, 21(5):798-804.
28. Frungieri M.B., Weidinger S., Meineke V., Kohn F.M., Mayerhofer A. Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma: Possible relevance to human fibrotic disorders. Proc. Natl. Acad. Sci. USA 2002, 99(23):15072-15077.
29. Fukushima K., Badlani N., Usas A., Riano F., Fu F., Huard J. The use of an antifibrosis agent to improve muscle recovery after laceration. Am. J. Sports Med. 2001, 29(4):394-402.
30. Gaedeke J., Peters H., Noble N.A., Border W.A. Angiotensin II, TGF-beta and renal fibrosis. Contrib. Nephrol. 2001, 135:153-160.
31. Garrett .E., Best T.M. Anatomy, physiology, and mechanics of skeletal muscle.Rosemont, IL. J. Am. Acad. Orthop. Surg. 1994.
32. Germain G., Delaney J., Moore G., Lee P., Lacroix V., Montgomery D. Effect of hyperbaric oxygen therapy on exercise-induced muscle soreness. Undersea Hyperb. Med.. 2003, 30(2):135-145.
33. Ghosh A.K. Factors involved in the regulation of type I collagen gene expression: Implication in fibrosis. Exp. Biol. Med.. (Maywood) 2002, 227(5):301-314.
34. Gosselin L.E., Martinez D.A. Impact of TNF-alpha blockade on TGF-beta1 and type I collagen mRNA expression in dystrophic muscle. Muscle Nerve 2004, 30(2):244-246.
35. Gosselin L.E., Williams J.E., Deering M., Brazeau D., Koury S., Martinez D.A. Localization and early time course of TGF-beta 1 mRNA expression in dystrophic muscle. Muscle Nerve 2004, 30(5):645-653.
36. Gregorevic P., Lynch G.S., Williams D.A. Hyperbaric oxygen improves contractile function of regenerating rat skeletal muscle after myotoxic injury. J. Appl. Physiol. 2000, 89(4):1477-1482.
37. Grounds M.D., Torrisi J. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J. 2004, 18(6):676-682.
38. Haapaniemi T., Sirsjo A., Nylander G., Larsson J. Hyperbaric oxygen treatment attenuates glutathione depletion and improves metabolic restitution in postischemic skeletal muscle. Free Radical Res. 1995, 23(2):91-101.
39. Harrison B.C., Robinson D., Davison B.J., Foley B., Seda E., Byrnes W.C. Treatment of exercise-induced muscle injury via hyperbaric oxygen therapy. Med. Sci. Sports Exerc. 2001, 33(1):36-42.
40. Hatae N., Sugimoto Y., Ichikawa A. Prostaglandin receptors: Advances in the study of EP3 receptor signaling. J. Biochem. Tokyo 2002, 131(6):781-784.
41. Hochberg M.C. NSAIDS:Mechanisms and pathways of action. Hosp. Pract. 1989, 24(3):185-190. Off Ed, 195, 198.
42. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51(6):919-928.
43. Horsley V., Pavlath G.K. Prostaglandin F2(alpha) stimulates growth of skeletal muscle cells via an NFATC2- dependent pathway. J. Cell Biol. 2003, 161(1):111-118.
44. Horsley ., Pavlath G.K. Forming a multinucleated cell:Molecules that regulate myoblast fusion. Cells Tissues Organs 2004, 176(1-3):67-78.
45. Huard J., Li ., Fu F.H. Muscle injuries and repair: current trends in research. J. Bone Joint Surg. Am. 2002, 84-A(5):822-832.
46. Hurme T., Kalimo H. Activation of myogenic precursor cells after muscle injury. Med. Sci. Sports Exerc. 1992, 24(2):197-205.
47. Ihn H. Pathogenesis of fibrosis: Role of TGF-beta and CTGF. Curr. Opin. Rheumatol. 2002, 14(6):681-685.
48. Jolly S.R., Kane .J., Hook B.G., Abrams G.D., Kunkel S.L., Lucchesi B.R. Reduction of myocardial infarct size by neutrophil depletion: Effect of duration of occlusion. Am. Heart J. 1986, 112(4):682-690.
49. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 1995, 16(1):3-34.
50. Kaariainen M., Jarvinen T., Jarvinen M., Rantanen J., Kalimo H. Relation between myofibers and connective tissue during muscle injury repair. Scand. J. Med.. Sci. Sports 2000, 10(6):332-337.
51. Karnes J.L., Burton H.W. Continuous therapeutic ultrasound accelerates repair of contraction-induced skeletal muscle damage in rats. Arch. Phys. Med.. Rehabil. 2002, 83(1):1-4.
52. Kasemkijwattana C., Menetrey J., Somogyl G., Moreland M.S., Fu F.H., Buranapanitkit B., Watkins S.C., Huard J. Development of approaches to improve the healing following muscle contusion. Cell Transplant. 1998, 7(6):585-598.
53. Korthuis R.J., Grisham M.B., Granger D.N. Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle. Am. J. Physiol. 1988, 254:H823-H827. 5 Part 2.
54. Lapointe B.M., Frenette J., Cote C.H. Lengthening contraction-induced inflammation is linked to secondary damage but devoid of neutrophil invasion. J. Appl. Physiol. 2002, 92(5):1995-2004.
55. Lescaudron L., Peltekian E., Fontaine-Perus J., Paulin D., Zampieri M., Garcia L., Parrish E. Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul. Disord. 1999, 9(2):72-80.
56. Li Y., Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am. J. Pathol. 2002, 161(3):895-907.
57. Li Y., Cummins J., Huard J. Muscle injury and repair. Curr. Opin. Orthop. 2001, 12:409-415.
58. Li ., Foster ., Deasy B.M., Chan ., Prisk ., Tang ., Cummins J., Huard J. Transforming growth factorbeta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenes. Am. J. Pathol. 2004, 164(3):1007-1019.
59. Lowe D.A., Warren G.L., Ingalls C.P., Boorstein D.B., Armstrong R.B. Muscle function and protein metabolism after initiation of eccentric contraction-induced injury. J. Appl. Physiol. 1995, 79(4):1260-1270.
60. Markert C.D., Merrick M.A., Kirby T.E., Devor S.T. Nonthermal ultrasound and exercise in skeletal muscle regeneration. Arch. Phys. Med.. Rehabil. 2005, 86(7):1304-1310.
61. Massimino M.L., Rapizzi E., Cantini M., Libera L.D., Mazzoleni F., Arslan P., Carraro U. ED2+ macrophages increase selectively myoblast proliferation in muscle cultures. Biochem. Biophys. Res. Comm. 1997, 235(3):754-759.
62. Mauro A. Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 1961, 9:493-495.
63. Mbebi C., Hantai D., Jandrot-Perrus M., Doyennette M.A., Verdiere-Sahuque M. Protease nexin I expression is up-regulated in human skeletal muscle by injury-related factors. J. Cell. Physiol. 1999, 179(3):305-314.
64. McCormack K. Roles of COX-1 and COX-2. J. Rheumatol. 1998, 25(11):2279-2281.
65. McCroskery S., Thomas M., Platt L., Hennebry A., Nishimura T., McLeay L., Sharma M., Kambadur R. Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice. J. Cell Sci. 2005, 118:3531-3541. Part 15.
66. McLennan I.S. Resident macrophages (ED2- and ED3-positive) do not phagocytose degenerating rat skeletal muscle fibres. Cell Tissue Res. 1993, 272(1):193-196.
67. McPherron A.C., Lawler .M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387(6628):83-90.
68. Mendias C.L., Tatsumi R., Allen R.E. Role of cyclooxygenase-1 and -2 in satellite cell proliferation, differentiation, and fusion. Muscle Nerve 2004, 30(4):497-500.
69. Menetrey J., Kasemkijwattana C., Day C.S., Bosch P., Vogt M., Fu F.H., Moreland M.S., Huard J. Growth factors improve muscle healing in vivo. J. Bone Joint Surg. Br. 2000, 82(1):131-137.
70. Mishra D.K., Friden J., Schmitz M.C., Lieber R.L. Anti-inflammatory medication after muscle injury. A treatment resulting in short-term improvement but subsequent loss of muscle function. J. Bone Joint Surg. Am. 1995, 77(10):1510-1519.
71. Monici M.C., Aguennouz M., Mazzeo A., Messina C., Vita G. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology 2003, 60(6):993-997.
72. Negishi S., Li Y., Usas A., Fu F.H., Huard J. The effect of relaxin treatment on skeletal muscle injuries. Am. J. Sports Med. 2005.
73. Obremsky .T., Seaber A.V., Ribbeck B.M., Garrett Jr..E. Biomechanical and histologic assessment of a controlled muscle strain injury treated with piroxicam. Am. J. Sports Med. 1994, 22(4):558-561.
74. Palmer R.M. Prostaglandins and the control of muscle protein synthesis and degradation. Prostag. Leukotr. Ess. Fatty Acids 1990, 39(2):95-104.
75. Porter J.D., Khanna S., Kaminski H.J., Rao J.S., Merriam A.P., Richmonds C.R., Leahy P., Li J., Guo W., Andrade F.H. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum.Mol. Genet. 2002, 11(3):263-272.
76. Prisk V., Huard J. Muscle injuries and repair: the role of prostaglandins and inflammation. Histol. Histopathol. 2003, 18(4):1243-1256.
77. Rantanen J., Hurme T., Lukka R., Heino J., Kalimo H. Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite ce. Lab. Invest. 1995, 72(3):341-347.
78. Rantanen J., Thorsson O., Wollmer P., Hurme T., Kalimo H. Effects of therapeutic ultrasound on the regeneration of skeletal myofibers after experimental muscle injury. Am. J. Sports Med. 1999, 27(1):54-59.
79. Roberts P., McGeachie J.K. The effects of pre- and posttransplantation exercise on satellite cell activation and the regeneration of skeletal muscle transplants: a morphometric and auto. J.Anat. 1992, 180:67-74. Part 1.
80. Sakamoto A., Matsumura J., Mii S., Gotoh Y., Ogawa R. A prostaglandin E2 receptor subtype EP4 agonist attenuates cardiovascular depression in endotoxin shock by inhibiting inflammatory cytokines and nitric oxide. Shock 2004, 22(1):76-81.
81. Sato K., Li Y., Foster W., Fukushima K., Badlani N., Adachi N., Usas A., Fu F.H., Huard J. Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis. Muscle Nerve 2003, 28(3):365-372.
82. Scheuren N., Jacobs M., Ertl G., Schorb . Cyclooxygenase-2 in myocardium stimulation by angiotensin-II in cultured cardiac fibroblasts and role at acute myocardial infarction. J.Mol. Cell. Cardiol. 2002, 34(1):29-37.
83. Shanmugasundaram T.K. Post-injection fibrosis of skeletal muscle: A clinical problem. A personal series of 169 cases. Int. Orthop. 1980, 4(1):31-37.
84. Shen ., Li Y., Tang Y., Cummins J., Huard J. NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis. Am. J. Pathol. 2005, 167(4):1105-1117.
85. Sirsjo A., Lehr H.A., Nolte D., Haapaniemi T., Lewis .H., Nylander G., Messmer K. Hyperbaric oxygen treatment enhances the recovery of blood flow and functional capillary density in postischemic striated muscle. Circ. Shock 1993, 40(1):9-13.
86. Skyhar M.J., Hargens A.R., Strauss M.B., Gershuni D.H., Hart G.B., Akeson W.H. Hyperbaric oxygen reduces edema and necrosis of skeletal muscle in compartment syndromes associated with hemorrhagic hypotension. J. Bone Joint Surg. Am. 1986, 68(8):1218-1224.
87. Smith H.K., Maxwell L., Rodgers C.D., McKee N.H., Plyley M.J. Exercise-enhanced satellite cell proliferation and new myonuclear accretion in rat skeletal muscle. J. Appl. Physiol. 2001, 90(4):1407-1414.
88. Smith J.K., Grisham M.B., Granger D.N., Korthuis R.J. Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am. J. Physiol. 1989, 256:H789-H793. 3 Part 2.
89. St Pierre B.A., Tidball J.G. Differential response of macrophage subpopulations to soleus muscle reloading after rat hindlimb suspension. J. Appl. Physiol. 1994, 77(1):290-297.
90. Stenson .F., Chang K., Williamson J.R. Tissue differences in vascular permeability induced by leukotriene B4 and prostaglandin E2 in the rat. Prostaglandins 1986, 32(1):5-17.
91. Strauss M.B., Hargens A.R., Gershuni D.H., Greenberg D.A., Crenshaw A.G., Hart G.B., Akeson W.H. Reduction of skeletal muscle necrosis using intermittent hyperbaric oxygen in a model compartment syndrome. J. Bone Joint Surg. Am. 1983, 65(5):656-662.
92. Tetsuka T., Daphna-Iken D., Srivastava S.K., Baier L.D., DuMaine J., Morrison A.R. Cross-talk between cyclooxygenase and nitric oxide pathways: Prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc. Natl Acad. Sci. USA 1994, 91(25):12168-12172.
93. Tidball J.G. Interactions between muscle and the immune system during modified musculoskeletal loading. Clin. Orthop. Relat. Res. 2002, 403(Suppl.):S100-S109.
94. Tidball J.G. Inflammatory processes in muscle injury and repair. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288(2):R345-R353.
95. Trappe T.A., Fluckey J.D., White F., Lambert C.P., Evans .J. Skeletal muscle PGF(2)(alpha) and PGE(2) in response to eccentric resistance exercise: influence of ibuprofen acetaminophen. J. Clin. Endocrinol. Metabol. 2001, 86(10):5067-5070.
96. Ulloa L., Doody J., Massague J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 1999, 397(6721):710-713.
97. Unemori E.N., Amento E.P. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J. Biol. Chem. 1990, 265(18):10681-10685.
98. Unemori E.N., Pickford L.B., Salles A.L., Piercy C.E., Grove B.H., Erikson M.E., Amento E.P. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J. Clin. Investig. 1996, 98(12):2739-2745.
99. Vandenburgh H.H., Shansky J., Solerssi R., Chromiak J. Mechanical stimulation of skeletal muscle increases prostaglandin F2 alpha production, cyclooxygenase activity, and cell growth by a pertussis toxin sensitive. J. Cell Physiol. 1995, 163(2):285-294.
100. Wanek L.J., Snow M.H. Activity-induced fiber regeneration in rat soleus muscle. Anat. Rec. 2000, 258(2):176-185.
101. Warner T.D., Mitchell J.A. Cyclooxygenase-3 (COX-3): Filling in the gaps toward a COX continuum?. Proc. Natl. Acad. Sci. USA 2002, 99(21):13371-13373.
102. Webster A.L., Syrotuik D.G., Bell G.J., Jones R.L., Hanstock C.C. Effects of hyperbaric oxygen on recovery from exercise-induced muscle damage in humans. Clin. J. Sport Med. 2002, 12(3):139-150.
103. Wilkin L.D., Merrick M.A., Kirby T.E., Devor S.T. Influence of therapeutic ultrasound on skeletal muscle regeneration following blunt contusion. Int. J. Sports Med. 2004, 25(1):73-77.
104. Williams E.J., Benyon R.C., Trim N., Hadwin R., Grove B.H., Arthur M.J., Unemori E.N., Iredale J.P. Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo. Gut 2001, 49(4):577-583.
105. Yamaguchi Y., Mann D.M., Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990, 346(6281):281-284.
106. Yamazaki M., Minota S., Sakurai H., Miyazono K., Yamada A., Kanazawa I., Kawai M. Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy. Am. J. Pathol. 1994, 144(2):221-226.
107. Zdanowicz M.M., Moyse J., Wingertzahn M.A., O'Connor M., Teichberg S., Slonim A.E. Effect of insulinlike growth factor I in murine muscular dystrophy. Endocrinology 1995, 136(11):4880-4886.